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We investigated the effects of red pepper (Capsicum annuum Lin.) extracts (capsicum extract) 
and its main pungent capsaicin on T helper 1 (Th1) and 2 (Th2) cytokine production in cultured 
murine Peyer’s patch (PP) cells in vitro and ex vivo. Direct administration of capsicum extract (1 and 
10 mg/ml) and capsaicin (3 and 30 mM) resulted in suppression of interleukin (IL)-2, interferon 
(IFN)-g, IL-4 and IL-5 production. In an ex vivo experiment using PP cells removed from the mice 
after oral administration of capsicum extract (10 mg/kg/day for 4 consecutive days), IL-2, IFN-g and 
IL-5 increased in response to concanavalin A (Con A). Oral administration of 3 mg/kg/day capsaicin, 
one active constituent of the extract, also enhanced IL-2, INF-g and IL-4 production in response to 
Con A stimulation but did not influence the production of IL-5. Orally administered capsazepine (3 
mg/kg/day) , a selective transient receptor potential vanilloid 1 (TRPV1) antagonist, slightly enhanced 
IL-2 production also irrespective of Con A stimulation. The capsaicin-induced enhancement of both 
IL-2 and IFN-g production was not reduced by oral administration of capsazepine (3 mg/kg/day), 
suggesting a TRPV1 receptor-independent mechanism. Flow cytometric analysis revealed that the 
population of CD3+ cells in the PP cells was significantly reduced while CD19+ cells increased after 
oral administration of capsicum extract (1 and 10 mg/kg/day) and capsaicin (0.3 and 3 mg/kg/day). 
Capsazepine (3 mg/kg/day) weakly but significantly reversed these effects. Orally administered 
capsicum extract and capsaicin did not change the T cell subset (CD4+ and CD8+), Th1 (IFN-g+) and 
T2 (IL-4+) ratio. These findings indicate that capsicum extract and capsaicin modulate T cell-immune 













TRPV1-dependent and -independent pathway. 
 














The inner surface of the intestinal tract possesses a large area of mucosal membranes, which are 
continuously exposed to various substances in the intestinal lumen (Mowat et al., 2003). 
Gut-associated lymphoid tissues exist on the intestinal mucosal site and play an important role in the  
immune system. Peyer’s patches (PP) are considered to be lymphoid tissues where mucosal immune 
responses such as local IgA production and systemic immunological responses are induced (Mowat et 
al., 2003). Antigen presentation in PP is important in determining systemic immune responses 
including T and B cell-dependent immunity (Mowat et al., 2003; Yoshida et al., 2002). Orally 
administrated hot water extract of cultured mycelia of Cordyceps sinensis (Berk.) Sacc was 
previously shown to increase interleukin (IL)-6 and granulocyte-colony stimulating factor (GM-CSF) 
production by PP cells in mice (Koh et al., 2002). Juzen-taiho-to, a Kampo prescription, was also 
shown to enhance production of these cytokines in PP cells from C3H/HeJ mice (Hong et al., 1998). 
Moreover, we recently reported that culture filtrate of the medicinal entomogenous fungi 
Paecilomyces tenuipes (Peck) Samson (= Isaria japonica  Yasuda or Isaria tenuipes) selectively 
enhanced T helper 1 cytokine production in cultured murine PP cells from C57BL/6J mice (Takano et 
al., 2005), and suggested that oral administration of the culture filtrate might increase immune 
responses (Takano et al., 1996), in part due to enhancement of these cytokines. Therefore, to elucidate 
the mechanisms of oral immune responses, examination of the cytokine modulating activities in 
cultured PP cells will be beneficial. 













also in traditional medicine against gastric ulcers, rheumatism, alopecia and toothache (Szallasi and 
Blumberg, 1999). Capsaicin is the most well-known and pungent active ingredient of Capsicum. 
Large numbers of studies have established that capsaicin shows various pharmacological effects and 
is endowed with a pleiotropic pattern of biological activities, some of which are mediated by the 
activation of cellular targets different from vanilloid receptor 1 (Szallasi and Blumberg, 1999). 
Capsaicin has also been shown to have immunomodulatory effects, as indicated by its ability to 
modulate lymphocyte proliferation and immunoglobulin A, E and G production (Nilsson et al., 1991, 
Eglezos et al., 1990), regulate the expression of substance P and its receptor in monocytes (Ho et al., 
1997), and inhibit cytosolic Ca2+ mobilization induced by platelet activating factor in the monocyte 
cell lines HL-60 (Choi et al., 2000). However, the systemic T-cell-dependent immune response after 
oral administration of capsaicin remains to be clarified.  
In this study, we therefore examine the effects of ethanolic extracts of C. annum, capsaicin and a 
vanilloid receptor-specific antagonist, capsazepine, on the production of T-helper cytokines in 
cultured PP cells in vitro and ex vivo. 
 
Materials and Methods  
Animals 
Male C57BL/6J mice, 6 to 10 weeks of age, were purchased from Japan SLC (Shizuoka, 
Japan). Mice were housed in groups of five in plastic cages with a 12 h light: 12 h dark cycle and free 













before commencing the experiment. The experimental procedures complied with the guidelines of the 
Council for Experimental Animals, the Faculty of Pharmaceutical Sciences, Kanazawa University, 
Japan. Mice were sacrificed by anesthetization with an overdose of ether. 
 
Materials 
RPMI-1640 medium, phosphate -buffered saline (PBS), fetal bovine serum (FBS), penicillin and 
streptomycin were obtained from Invitrogen Corp. (Carlsbad, CA USA). Concanavalin A (Con A) 
(type IV), type I collagenase, capsaicin and capsazepine were obtained from Sigma Chem. Co. (St. 
Louis, MO). All other reagents were purchased from Wako Pure Chemical Co. (Tokyo, Japan). For 
analysis of the T, B and T cell subset (CD4+ and CD8+) in PP cells, the following monoclonal 
antibodies (mAb, Beckman Coulter Inc., Hialeah, FL) were used: anti-CD45RA-fluorescein 
isothiocyanate (FITC) antibodies (RA3-6B2, IgG2a), anti-CD3-FITC antibodies (KT3, IgG2a), 
anti-CD4-FITC antibodies (YTS191.1, IgG2b), anti-CD8-phycoerythin (PE) antibodies (KT15, 
IgG2a), anti-IFN-g-FITC antibodies (XMG1.2, IgG1) and anti-IL-4-FITC antibodies (BVD-24G2, 
IgG1). The isotype-matched controls used in this experiment were IgG1 conjugated to FITC, IgG2a 
conjugated to PE, IgG2a conjugated to FITC and IgG2b conjugated to FITC. 
 
Extraction and isolation 
Capsicum annum L. for medicinal use was purchased from Uchida Wakanyaku Co. Ltd. (Tokyo, 













Pharmaceutical Sciences, Kanazawa University, Japan. 
The dried fruits (1.0 kg) of C. annum were macerated in 95% ethanol (EtOH) (1 L, 3 times) at 
room temperature for 24 h. After filtration, the ethanol solution was evaporated under reduced 
pressure to give ethanol extract (capsicum extract) (26 g). Capsicum extract (10 g) was then subjected 
to column chromatography on silica gel (500 g). Elution with a mixture of hexane-ethylacetate 
(AcOEt) and methanol (MeOH) gave 14 fractions: Fr-1 (5% AcOEt, 1200 ml, 698 mg), Fr-2, (25% 
AcOEt, 300 ml, 675 mg), Fr-3 (25% AcOEt, 300 ml, 120 mg), Fr-4 (25% AcOEt, 300 ml, 46 mg), 
Fr-5 (25% AcOEt, 300 ml, 54 mg), Fr-6 (35% AcOEt, 1200 ml, 458 mg), Fr-7 (50% AcOEt, 600 ml, 
78 mg), Fr-8 (50% AcOEt, 600 ml, 210 mg), Fr-9 (65% AcOEt, 1200 ml, 1104 mg), Fr-10 (75% 
AcOEt, 600 ml, 119 mg), Fr-11 (75% AcOEt, 600 ml, 80 mg), Fr-12 (90% AcOEt, 600 ml, 141 mg), 
Fr-13 (100% AcOEt, 1200 ml, 2844 mg), and Fr-14 (100% MeOH, 1200 ml, 4319 mg). Fr-2 (10 mg) 
eluted with 25% AcOEt was determined as being composed mainly of carotenoids and was further 
subjected to high performance liquid chromatography (HPLC; ODS, acetone-H2O, 90:10) to give the 
main constituent, b-carotene (3.7 mg, Fig. 1). Fr-9 (10 mg) eluted with 65% AcOEt was determined 
as being composed mainly of capsaicinoids and was also subjected to HPLC (silica gel, 
hexane-acetone, 65:35) to give capsaicin (4.1 mg, Fig. 1). The structures of the carotenoids and 
capsaicinoids were determined by comparing their spectral data with those reported in the literature 
(Maillard et al., 1997; Mercadante et al., 1999). For ex vivo experiments, capsaicin was purchased 
from Sigma Chem. Co. (St. Louis, MO). The purity of the capsaicin was checked and further purified 














Peyer’s patch (PP) cell preparation 
C57BL/6J mice were sacrificed with an overdose of ether and their small intestines were placed 
into a petri dish filled with PBS containing penicillin (100 U/ml) and streptomycin (100 mg/ml) on ice 
(Manhart, 2001). Visible PPs were carefully dissected out from the wall of the small intestines using 
micro scissors under a microscope (10 Peyer’s patches were obtained from each mouse), and were 
placed in ice-cold complete RPMI-1640 medium containing 5% FBS, 50 µM 2-mercaptoethanol, 100 
U/ml penicillin and 100 µg/ml streptomycin. To obtain a single PP cell suspension, the PPs were 
digested with type 1 collagenase (70 U/ml) dissolved in the same medium and incubated for 60 min at 
37 oC. After filtration through a 200 mm nylon mesh (Becton Dickinson, Oxnard, CA, USA), the PP 
cells were washed three times with complete medium. Cell viability was assessed by trypan blue 
exclusion. Morphological analysis by characteristic non-specific esterase and Giemsa staining 
revealed that more than 97% of the cells were lymphoids and less than 1% were monocytes. PP cells 
(3 ´ 106 cells/ml) suspended in complete medium were seeded in a 24-well tissue culture plate 
(Becton Dickinson) and cultured with or without 5 mg/ml Concanavalin A (Con A).(Takano et al., 
2004)  
 
Test sample treatment 
Capsicum extracts, fractions, capsaicin and capsazepine were suspended in medium containing 













added with or without Con A. For ex vivo assay, capsicum extract (1, 3 and 10 mg/kg/day) or 
fractions (3 mg/kg/day) suspended in 10% EtOH and 50 ml/20g body weight solution was orally 
injected into mice once a day for four consecutive days. Capsaicin (0.3 and 3 mg/kg/day) or 
capsazepine (3 mg/kg/day) (Costa et al., 2004) also suspended in 10% EtOH and 50 ml/20g body 
weight solution was orally injected into mice once a day for four consecutive days. In other case, mice 
were injected orally with 3 mg/kg/day capsaicin simultaneously with 3 mg/kg/day capsazepine in the 
same regimen. Control groups received a vehicle (10% EtOH) instead of test samples. In this 
experiment, capsaicin dosage was estimated by capsaicinoids concentration in the effective doses of 
both capsicum extract (1 to 2% (w/w) of the extract) (10 mg/kg) and Fr-9 (3 mg/kg) (49 to 51% of the 
Fr-9) ex vivo. 
 
Cytokine evaluation 
To measure cytokine production in cultured PP cells, culture supernatants were collected at 72 h 
and stored at -80 oC until use. The levels of IL-2, IL-4, IL-5 and INF-g in the supernatants were 
measured by enzyme linked immunosorbent assay (ELISA) using commercial kits (CytoscreenTM, 
BIOSOURCE, Camarillo, CA, USA) according to the manufacturer’s instructions.  
 
PP cell viability 
To assess the correlation between PP cell cytotoxicity and suppression of cytokine production by 













and cultured with or without 5 mg/ml Con A for 72 h. The supernatants were then removed and 
remaining PP cells were added to fresh medium containing MTT solution (50 ml of 5 mg/ml in PBS). 
The mixture was incubated for 5 h at 37 oC then the reduced formazan was solubilized with 0.5 ml of 
detergent (10% SDS in 0.05N HCl) for 18 h. Absorbance of the MTT-formazan solution at 590 nm 
was read using an immunoreader. Cell viability data were recorded as the absorbance ratio 
(percentage) of the test sample-treated PP cells to non-treated PP cells (Mosmann, 1983). In the ex 
vivo assay, PP cell viability of treated mice was measured by trypane blue staining (0.4% in PBS). 
 
Flow cytometry 
PPs (10 /mouse) were collected after 6-days oral injection of extracts, fractions, capsaicin or 
capsazepine, and dissociated into a single-cell suspension by filtrating through a 200 mm nylon mesh. 
Erythrocytes in the PP cell suspensions were lysed in 0.75% ammonium chloride buffer (pH 7.6). The 
resultant cells were counted and resuspended in PBS. Cells (1 ´ 106) were stained with fluorochrome 
directly conjugated with mAb (Macey, 1999): anti-CD3-FITC, anti-CD45RA-FITC, 
anti-CD4-FITC/anti-CD8-PE, anti-IFN-g-FITC and anti-IL-4-FITC or isotype-matched controls. 
After 60 min incubation at 4 °C, the cells were washed and resuspended in PBS containing 1 mg/ml of 
propidium iodide. The lymphocyte population in the PP cells was analyzed using a flow cytometer 
(FACScanTM, Becton Dickinson, San Jose, CA, USA) as described below. Gates were set by forward 
and side scatter to delineate leukocytes and exclude dead cells; death was confirmed by propidium 














Data analysis for flow cytometry 
Data were acquired using Cell Quest TM software (Becton Dickinson). Between 10,000 and 
20,000 events were acquired per sample. All data were representative plots derived from a minimum 
of three independent experiments in which at least three experimental and three or four control mice 
were analyzed. Mean FITC- and FTIC-/PE-fluorescence intensities were calculated from 
fluorescence histograms for the gated population. 
 
Statistical analysis 
The mean cytokine production and ratio of lymphocyte or T lymphocyte subpopulations were 
considered as a single data point for analysis of results from at least three or four independent 
experiments. All data are expressed as the mean ± SE. Statistical significance was determined by 
Dunnett’s multiple test after one-way analysis of variance (ANOVA) with comparison to a control 
group, and the differences were considered significant if p<0.05. 
 
Results 
The murine intestine is a highly regulated immune system producing large amounts of 
regulatory cytokines, with immune responses dominated by Th2 type cytokines rather than Th1 
cytokines (Xu-Amano, 1993). IL-2 and IFN-g are the major Th1 cytokines involved in cellular 













(Romagnani, 2004; Sood, 2005).  
We previously reported IL-2, IL-4, IL-5 and IFN-g production in PP cells upon non-specific 
T-cell stimulation with Con A (Takano et al., 2004); these cytokines were produced 12 h after Con A 
(5 mg/ml) challenge, increased over 72 h and slightly decreased at 96 h. No increment of these 
cytokines was observed when the PP cells were cultured without Con A. Based on these data, the 
present study examined the effects of capsicum extract and capsaicin on PP cell cytokine production 
72 h after Con A challenge both in vitro and ex vivo. 
PP cells isolated from C57BL/6J mice produced a large amount of IL-2, IL-4, IL-5 and IFN-g 72 
h after Con A stimulation (Figs. 2A, B, C and D). As shown in Fig. 2, capsicum extract and capsaicin 
strongly inhibited Con A-induced cytokine productions in a concentration-dependent manner. 
Capsicum extract significantly suppressed four different kinds of T helper cytokines by >90% at a 
concentration of 10 mg/ml (Fig. 2). Capsaicin, one of the main bitter constituents, completely reduced 
these cytokines at a concentration of 3 mM (Fig. 2). To examine the PP cell viability, cells were treated 
with test samples at the same concentrations. A significant cytotoxic effect against the PP cells 
irrespective of Con A stimulation was observed even at concentrations of 10 mg/ml (for extract) and 3 
mM (for capsaicin) (Table 1), which significantly suppressed T helper cytokine production (Fig. 2). 
Since capsicum extract and capsaicin suppressed production of T helper cytokines in the 
cultured PP cells in vitro, we next examined the ex vivo effect of these samples on cytokine 
production. Capsicum extract was injected into mice once a day for 4 consecutive days then 2 days 













cytokines. In this experiment, oral injection of capsicum extract and capsaicin showed no toxicity to 
mice, demonstrated by the fact that the body and liver weights (data not shown) and level of plasma 
hepatic marker enzyme, alanine aminotransferase (ALT, EC 2.6.1.2), did not change (10 mg/kg/day 
capsicum extract: 22.1 + 1.0 U/ml, n=7, not significant; 3 mg/kg/day capsaicin: 26 + 2.9 U/ml, n=6, 
not significant; vehicle only: 18.3 + 1.1 U/ml, n=3). In contrast to the in vitro study (Fig. 2), the 
production of IL-2 and IFN-g in PP cells from mice injected with capsicum extract was much more 
than in those of control mice, especially in response to Con A stimulation (Fig. 3). Oral injection of 
the extract enhanced Th1 cytokines in response to Con A at doses of 1 to 10 mg/kg in a 
dose-dependent manner (Figs. 3B and D). Next we examined the influence of the extract on IL-4 and 
IL-5 production in the PP cells ex vivo. IL-4 and IL-5 are signature cytokines produced by Th2 and 
are able to direct developing Th0 cells to differentiate into Th2 cells ( Xu-Amano, 1993; Romagnani, 
2004). EtOH extract did not affect IL-4 production in the PP cells in both the presence and absence of 
Con A stimulation, whereas it moderately but significantly enhanced IL-5 production by 180.9% 
(p<0.05) irrespective of Con A (Fig. 4). 
In order to isolate the active constituent(s) responsible for Th1 activation (Fig. 2), the capsicum 
extract was separated into 14 fractions by column chromatography on silica gel. Fig. 5 shows that the 
stimulatory effect on IL-2 and IFN-g production in cultured PP cells transferred mainly to Fr-2 and 
Fr-9, which increased the IL-2 and IFN-g production co-stimulated with Con A by 187 ± 16% (IL-2 
level, Fr-2, p<0.05), 213 ± 20% (IL-2 level, Fr-9, p<0.05), 124 ± 27% (IFN-g level, Fr-2, not 













gel chromatography and HPLC. Fr-2 was shown to consist mainly of carotenoids (b-carotene; Fig. 1). 
Fr-9 was mainly composed of capsaicinoids and capsanthin (Fig. 1). Fr-2 showed a toxic action 
against PP cells at concentrations over 3 mg/ml, whereas Fr-9 was not toxic at the same concentrations 
(Table 1). On the other hand, oral injection of Fr-2 at dose of 3 mg/kg/day for 4 consecutive days did 
not show any significant toxicity to PP cells (Table 2). 
Capsaicin has also been shown to have modulatory effects to B cell immune responses (Nilsson 
et al., 1991;  Eglezos  et al., 1990). In the present experiment, we therefore noted the richness of Fr-9 in 
capsaicinoids, which potentiated IL-2 and IFN-g production similar to Fr-2, and evaluated the effect 
of capsaicin, a major pungent component of Capsicum, on cytokine production in PP cells ex vivo. 
PP cells from mice treated with capsaicin at doses of 0.3 and 3 mg/kg/day produced IL-2 and 
IFN-g unlike those from control mice (Figs. 6A-D), whereas orally injected capsaicin at the same 
doses did not affect IL-5 production (Figs. 7A-D). The levels of IL-4 co-stimulated with Con A in the 
PP cells from capsaicin-treated mice rose approximately 1.4 times more than those from the control 
(Fig. 7B). 
It is well known that capsaicin and other pungent vanilloids activate a cell surface receptor 
called transient receptor potential vanilloid 1 (TRPV1), which is expressed mainly in nociceptive 
neurons. TRPV1 is a cation channel activated by pungent vanilloid compounds, extracellular protons 
or noxious heat and plays a central role in neurogenic inflammation (Szallasi, 2001; Szallasi and 
Blumberg, 1999). To clarify the relationship between the capsaicin-induced enhancement of cytokine 













antagonist capsazepine (Fig. 1) was examined in capsaicin-treated mice. As shown in Figs. 6 and 7, 
IL-2 and IFN-g production in PP cells co-stimulated with Con A were significantly potentiated by oral 
administration of capsazepine alone at a dose of 3 mg/kg/day (Figs. 6B and D). Oral administration of 
capsazepine alone also accelerated Con A-stimulated IL-4 production, but did not accelerate IL-5 
production at the same dose (Figs. 7B and D). Administration of capsazepine (3 mg/kg/day) 
simultaneously with capsaicin (3 mg/kg/day)  resulted in enhanced IL-2 production in response to Con 
A (Fig. 6B), while  the secretion of IFN-g, IL-4 and IL-5 in PP cells was not affected (Figs. 6 and 7). 
We determined the number of PP cells from mice orally treated with tested samples. T he number 
of PP cells from normal mice was 26.1 ± 1.0 (´  106) cells/mouse. Orally administered capsicum 
extract significantly increased PP cell number, whereas capsaicin (3 mg/kg/day) decreased the 
number of PP cells (Table 1). Administration of capsazepine alone or capsazepine + capsaicin had no 
effect on the number of PP cells (Table 1). Oral administration of capsicum extract, capsaicin and 
capsazepine, respectively, caused no cytotoxicities toward PP cells in contrast to the in vitro 
experiment (Table 2).  
To clarify what kinds of T lymphocytes when treated with capsicum extract, capsaicin, 
capsazepine and capsaicin + capsazepine increase or decrease the PP cells, PP cells were stained with 
FITC- or PE-conjugated specific T, B and T helper-subset lineage markers and subjected to flow 
cytometric analysis. PP cells are mainly composed of T and B cells, and it is well understood that T 
cells are a source of immunomodulatory cytokine production (Bhide et al., 2001). Flow cytometric 













27.1% and 69.4%, and that of the T cell subpopulation, CD4+ and CD8+, were 25.2% and 5.9%, 
respectively (Table 3). After administration of higher doses (3 mg/kg/day) of both capsicum extract or 
capsaicin, the percentage of CD3+ cells decreased from 7 to 10% of the total T cell population, 
whereas they increased CD19+ B lymphocytes by 78.1% (capsicum extract, p<0.05) and 77.0% 
(capsaicin, p<0.05) at 10 and 3 mg/kg/day. On the other hand, capsazepine did not change the 
percentages of T and B cells, the T cell subset and T helper subset in PP cells (Table 3). The 
populations of IFN-g and IL-4 positive cells in the T lymphocytes significantly decreased with 
capsaicin treatment (3 mg/kg/day) but the ratio of the T helper subset was unchanged (control group, 
IFN-g+:IL-4+ = 1:1.76; capsaicin IFN-g+:IL-4 = 1:1.88). Administration of the TRPV1 antagonist 




The present study demonstrated that ethanol extract of red pepper (C. annum) and its main 
piquant component capsaicin directly inhibit T helper cytokine production in cultured PP cells in vitro, 
whereas oral injection enhances the levels of IL-2 and IFN-g in response to Con A. The capsicum 
extracts and capsaicin had an opposite effect on immune responses in vitro and ex vivo, suggesting an 
indirect effect in vivo. Capsicum has shown a wide range of pharmacological properties including 
pain relief, antigenotoxic, antimutagenic, and anticarcinogenic effects (Surh and Lee, 1995). To our 













and capsaicin regulate the production of T helper 1 cytokines such as IL-2 and IFN-g in PP cells. 
Capsaicin reportedly causes cell death of neuronal cells (Szallasi and Blumberg, 1999) as well 
as non-neuronal cells and cell lines such as Vero monkey kidney cells (Creppy et al., 2000), SHSY-5Y 
human neuroblastoma cells (Richeux et al., 1999), ECV340 human endothelial cells (Richeux et al., 
2000), A172 human glioblastoma cells (Lee et al., 2000), BEAS-2B human bronchiolar epithelial 
cells and A549 human lung adenocarcinoma cells (Reilly et al., 2003), and a variety of other cell lines. 
Further, functional vanilloid receptors have been found on rat CD3high as well as CD3negative 
thymocytes and are associated with the selective ability of capsaicin to trigger DNA fragmentation in 
thymocytes (Amantini et al., 2004). In the present study, direct treatment of PP cells with capsaicin 
reduced cell viability at concentrations of 3 and 30 mM (Table 1). Furthermore, oral administration of 
capsaicin at a dose of 3 mg/kg (for 4 consecutive  days) selectively reduced the CD3+ T cell population 
without changing the ratio of Th1/Th2 cells in the PP, and capsazepine, a prototype of the TRPV1 
antagonist, ameliorated the capsaicin-induced reduction of CD3+ T cells (Table 3). Thus, it is 
reasonable to assume that TRPV1 is also expressed on T lymphocytes in PP and that the 
capsaicin-induced T cell reduction was mediated by its interaction with TRPV1 since it was partly 
inhibited by capsazepine.  
Previous research has demonstrated that capsaicin inhibits IL-2 production (Gertsch et al., 
2002) by capacitative calcium entry in Jurkat cells (Fischer et al., 2002). Capsaicin has also been 
reported to suppress cell surface expression of CD69, CD25 and ICAM-1 on Jurkat cells in vitro 













showed concentration-dependent suppression of IL-2, IFN-g, IL-4 and IL-5 (Fig. 2) secretions in 
cultured PP cells, dramatically reducing their viability (Table 2). Our in vitro data were in agreement 
with previous reports in which capsaicin reduced T cell function and cytokine production (Gertsch et 
al., 2002; Bruce et al., 2002; Sancho et al., 2002). 
Unexpectedly, PP cells from mice injected orally with capsicum extract or capsaicin 
significantly secreted Th1 cytokines, IL-2 and IFN-g, in response to Con A (Fig. 3). Further, the 
increment of IL-2 and IFN-g production with capsaicin treatment could not be abolished when the 
TRPV1 antagonist capsazepine was simultaneously administered (Figs. 6 and 7). Interestingly, the 
same dosage (3 mg/kg/day) and regimen (4 consecutive days) of capsazepine significantly increased 
Con A-induced IL-2 and IFN-g production in cultured PP cells. These results indicated that TRPV1 
agonist capsaicin and its antagonist capsazepine showed stimulatory effects on Th1 cytokine 
production ex vivo through a TRPV1-independent pathway.  
Capsaicin-sensitive primary afferents are well known to be involved in nociception and 
neurogenic inflammation. In contrast to its acute excitatory activity, capsaicin also exhibited 
analgesic properties, when used to treat pain associated with diabetic neuropathies or rheumatoid 
arthritis (Szallasi and Blumberg, 1999; Tominaga and Tominaga, 2005). This paradoxical effect 
correlated to the ability of capsaicin to desensitize nociceptive terminals following long-term 
exposure (Tominaga and Tominaga, 2005). In our experiment, a short-term administration (once a 
day for 4 consecutive days) of capsaicin showed stimulatory effect on Th1 cytokine production in PP 













clarify relationship between capsaicin-induced T helper 1 cytokines production in PP cells and 
function of TRPV1 ex vivo. We are now planning to investigate the effects of short-term and 
long-term administration of capsaicinoids on the production of T helper cytokines in PP cells by using 
TRPV1 knockout mice in the next step.  
Recently, it was reported that an intraplantar injection of capsaicin into the dorsal aspect of the 
rat hind paw produced early upregulation of proinflammatory cytokines such as IL -1b, TNF-a, IL-6, 
and nerve growth factor  (Saade et al., 2002). Basu and Srivastava (2005) more recently showed that 
bone marrow -derived mouse dendritic cells express TRPV1, and that ligand capsaicin transmits the 
immunological inflammatory signals. Thus, it is assumed that in vivo administration of capsaicin 
might up-regulate T cell immune responses and that the mechanisms of the immunopotent effect of 
capsaicin might be TRPV1 independent. More specifically, capsaicin is known to mediate 
neuroactive ligands such as Substance P, bradykinins and enkephalins (Wang, 2005). It is also 
noteworthy that Substance P and bradykinins have been shown to mediate NF-kB, a transcriptional 
factor central to innate immune responses (Pan et al., 1996; Lieb et al., 1997). Endogenously 
produced Substance P has been shown to contribute to lymphocyte proliferation by activation of 
dendritic cells and T cell antigen receptor ligation (Lambrecht et al., 1999). Indeed, PP cells from 
mice intravenously injected with Substance P at dose of 27 ng/kg strongly secreted IL-2 and IFN-g 
irrespective of Con A (unpublished data). Moreover, we also found that an intravenous injection (0.1 
mg/kg) of neurokinin-1 receptor antagonist, sendide (Sakurada et al., 1989), completely abolished the 













therefore be discussed that the mechanisms by which capsaicin potentiated Th1 cytokine production 
ex vivo was in part due to endogenous neuropeptide Substance P. Further investigation in line with 
this idea is underway.  
Most pharmacological studies performed so far have focused on capsaicinoids; however, the 
medicinal properties attributed to capsicum might be related to different compounds. In this 
experiment, the active fractions in capsicum extract, which enhanced T helper cytokine production, 
were shown to be not only a fraction rich in capsaicinoids (Fr-9) but also one rich in carotenoids 
(Fr-2) (Fig. 5). HPLC analysis of Fr-2 revealed that it contained mainly b-carotene (Fig. 1), 
b-cryptoxanthin, and lycopene. Satoh et al., (2004) recently reported that splenocytes from mice fed 
b-carotene (Fig. 1) produced more IL-2 and IFN-g than those from control mice. Thus, it is possible to 
suggest that the immunopotent activity of capsicum extract might also be due to carotenoids in the 
extract. Further purification and chemical characterization of Fr-2 as well as evaluation of their 
inductive effects on T helper cytokines in PP cells are necessary.  
In summary, the present study demonstrated that orally administered capsicum extract and its 
main pungent capsaicin selectively modulate the production of T helper 1 cytokines such as IL-2 as 
well as IFN-g, but have no significant effect on the levels of IL-4 and IL-5, via a TRPV1-independent 
pathway. These findings suggest that capsicum extract and capsaicin do not cause non-specific 
immune responses like those induced by Con A. Further, the balance between Th1 and Th2 is of 
central importance for immune responses of mucosal T cells (Neurath et al., 2002). It is also indicated 













asthma (Neurath et al., 2002). Taken together, a moderate intake of capsicum or capsaicin has 
potentialities as therapeutic or preventive agents for treatment of immune diseases such as allergies 
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Figure legends  
 
Fig. 1. Chemical structures of b-carotene, capsaicin and capsazepine. 
 
Fig. 2. Suppressive effects of capsicum extract and capsaicin on IL-2, IFN-g, IL-4 and IL-5 
production in cultured PP cells in vitro. PP cells were directly treated with capsicum extract or 
capsaicin + 5 mg/ml Con A. The culture supernatants were collected at 72 h after Con A stimulation 
and cytokine production was measured using ELISA. Panel A: IL-2 production, panel B: 
IFN-g production, panel C: IL-4 production and panel D: IL-5 production. All data are expressed as 
the mean ± SD of quadruplicate cultures, a p<0.05 and b p<0.01 compared with control cultures. 
Results of one experiment repeated twice with similar results. CE: capsicum extract. 
 
Fig. 3. Effects of capsicum extract on IL-2 and IFN-g production in cultured PP cells ex vivo. Mice 
were treated orally with capsicum extract or vehicle once a day for 4 consecutive days, and the PP 
cells were collected 6 days after the first day of treatment and cultured in the absence or presence of 5 
mg/ml Con A for 72 h. IL-2 and IFN-g production in the cultured supernatants were measured using an 
ELISA kit. Panel A: IL -2 production in PP cells without Con A stimulation, panel B: IL-2 production 
in PP cells with Con A stimulation, panel C: IFN-g production in PP cells without Con A stimulation 
and panel D: IFN-g production in PP cells with Con A stimulation. All data are expressed as the mean 













repeated twice with similar results. CE: capsicum extract. 
 
Fig. 4. Effects of capsicum extract on IL-4 and IL-5 production in cultured PP cells ex vivo. Mice 
were treated orally with capsicum extract or vehicle once a day for 4 consecutive days, and the PP 
cells were collected 6 days after the first day of treatment and cultured in the absence or presence of 5 
mg/ml Con A for 72 h. IL-4 and IL-5 production in the cultured supernatants were measured using an 
ELISA kit. Panel A: IL -4 production in PP cells without Con A stimulation, panel B: IL-4 production 
in PP cells with Con A stimulation, panel C: IL-5 production in PP cells without Con A stimulation 
and panel D: IL-5 production in PP cells with Con A stimulation. All data are expressed as the mean ±  
SD of quadruplicate cultures, a p<0.05 compared with control cultures. Results of one experiment 
repeated twice with similar results. CE: capsicum extract. 
 
Fig. 5. Effects of fractions separated from the capsicum extract on IL-2 and IFN-g production in 
cultured PP cells ex vivo. Mice were treated orally with a fraction or vehicle once a day for 4 
consecutive days, and the PP cells were collected 6 days after the first day of treatment and cultured in 
the absence or presence of 5 mg/ml Con A for 72 h. IL-2 and IFN-g production in the cultured 
supernatants were measured using an ELISA kit. Panel A: IL-2 production in PP cells without Con A 
stimulation, panel B: IL-2 production in PP cells with Con A stimulation, panel C: IFN-g production 
in PP cells without Con A stimulation and panel D: IFN-g production in PP cells with Con A 













with control cultures. Results of one experiment repeated twice with similar results. CE: capsicum 
extract. 
 
Fig. 6. Effects of capsaicin and capsazepine on IL-2 and IFN-g production in cultured PP cells ex 
vivo. Mice were treated orally with capsaicin (Cap), capsazepine (CZ), capsaicin + capsazepine 
(Cap/CZ) or vehicle  once a day for 4 consecutive days, and the PP cells were collected 6 days after the 
first day of treatment and cultured in the absence or presence of 5 mg/ml Con A for 72 h. IL-2 and 
IFN-g production in the cultured supernatants were measured using an ELISA kit. Panel A: IL-2 
production in PP cells without Con A stimulation, panel B: IL-2 production in PP cells with Con A 
stimulation, panel C: IFN-g production in PP cells without Con A stimulation and panel D: IFN-g 
production in PP cells with Con A stimulation. All data are expressed as the mean ± SD of 
quadruplicate cultures, a p<0.05 compared with control cultures. Results of one experiment repeated 
twice with similar results. 
 
Fig. 7. Effects of capsaicin and capsazepine on IL-4 and IL-5 production in cultured PP cells ex vivo. 
Mice were treated orally with capsaicin (Cap), capsazepine (CZ), capsaicin + capsazepine (Cap/CZ) 
or vehicle  once a day for 4 consecutive days, and the PP cells were collected 6 days after the first day 
of treatment and cultured in the absence or presence of 5 mg/ml Con A for 72 h. IL-4 and IL-5 
production in the cultured supernatants were measured using an ELISA kit. Panel A: IL-4 production 













panel C: IL-5 production in PP cells without Con A stimulation and panel D: IL-5 production in PP 
cells with Con A stimulation. All data are expressed as the mean ± SD of quadruplicate cultures, a 





























*PP cells were cultured with capsicum extract or capsaicin at the indicated concentrations together 
with 5 mg/ml Con A for 72 h. Cytokine production (Fig. 2) and cell viability were then measured by 
MTT methods (see the materials and methods). Cell viability data represent the absorbance ratio 
(percentage) of sample-treated PP cells to non-treated PP cells. a p<0.05 and b p<0.01 compared with 
Con A-treated control cultures. 
 
 
Treatment Concentration Cell viability (%) 
Con A(-) 
Cell viability (%) 
Con A (+) 
n 
- - 96.8 + 2.2 90.2 + 1.9 4 
Capsicum extract 1 mg/ml 83.1 + 1.7 a 76.1 + 1.1 a 3 
 10 mg/ml 67.2 + 1.0 b 64.4 + 2.2 b 4 
Fr-2 3 87.1 + 1.4 a 74.4 + 2.6 b 4 
 10 70.4 + 1.0 b 63.0 + 1.0 b 4 
Fr-9 3 93.3 + 1.1 92.1 + 1.3 3 
 10 94.6 + 0.4 87.0 + 1.8 4 
Capsaicin 3 mM 73.3 + 2.9 b 73.9 + 1.9 a 3 





































Takano et al., Table 3 
Table 3 







*Capsicum extract, capsaicin, capsazepine or capsaicin + capsazepine were injected orally once a day for 4 consecutive days. PP cells (1 ´  106 cells) were 
collected 2 days after the final injection and stained w ith lineage specific FITC- or PE-conjugated mAb. Data are expressed as the mean ± S.E. of 5-6 mice. 
a p<0.05 compared with the control mice.  
Treatment Dose CD3+ CD19+ CD4+ CD8+ IFN-g+ IL-4+ n 
 (mg/kg/day) (%) (%) (%) (%) (%) (%)  
Control - 27.1 + 1.6 69.4 + 3.5 25.2 + 2.1 5.9 + 0.7 9.2 + 0.3 16.2 + 0.1 7 
Capsicum extract 1 25.8 + 1.9 69.6+ 1.9 19.0 + 0.9 5.3 + 1.1 8.1 + 1.7 14.9 + 0.2 6 
 10 20.4 + 1.0 a 78.1 + 1.6 a 17.4 + 1.0 a 5.1 + 1.2 8.5 + 1.2 15.0 + 1.8 6 
Capsaicin 0.3 22.1 +1.4 74.1 + 1.3 21.3 + 1.5 5.2 + 0.4 8.7 + 0.9 14.8 + 0.3 6 
 3 17.6 + 0.3 a 77.0 + 2.1 a 13.3 + 1.2 a 4.8 + 1.0 5.0 + 0.3 a 9.4 + 2.2 a 6 
Capsazepine 3 29.9 + 2.1 68.4 + 0.7 20.6 + 0.8 7.2 + 0.3 8.3 + 0.4 14.0 + 1.0 5 
Capsaicin/capsazepine 3 + 3 28.7 + 0.4 66.3 + 0.2 24.2 + 0.3 4.2 + 0.1 8.8 + 0.4 13.5 + 0.6 5 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
